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se incrementa en 2%(t= 3.779, p= 0.000). Respecto a la tenencia de seguro social la 
probabilidad de comprar medicamentos se reduce en -0.201 o un riesgo relativo de 
compra de 0.818 (Wald= 4.241, p= 0.039). ConClusiones: Existe una mayor vul-
nerabilidad de la población indígena, respecto al acceso a medicamentos. Se hace 
necesario desarrollar estrategias e intervenciones sanitarias para mejorar el acceso, 
disponibilidad y costo de medicamentos en Panamá.
PRM14
CalibRation of PieCewise MaRkov Models Using a Change-Point 
analysis thRoUgh an iteRative Convex oPtiMization algoRithM
Alarid-Escudero F, Enns E, Peralta-Torres YE, Maclehose R, Kuntz KM
University of Minnesota, Minneapolis, MN, USA
objeCtives: Relative survival represents cancer survival in the absence of other 
causes of death. Cancer Markov models often have a distant metastasis state, a 
state not directly observed, from which cancer deaths are presumed to occur. The 
aim of this research is to use a novel approach to calibrate the transition probabili-
ties to and from an unobserved state of a Markov model to fit a relative survival 
curve. Methods: We modeled relative survival for newly diagnosed cancer patients 
through a piecewise Markov model. For each segment we used a constant transition 
matrix with three cancer states: 1) no evidence of disease, 2) metastatic recurrence 
and 3) cancer death. We estimated the optimal time points at which the slope of the 
cumulative hazard changes using a free-knot spline model. We calibrated the transi-
tion probabilities using a two-step iterative convex optimization (TICO) algorithm. 
The dynamics of the disease can be defined as xt+1= xtA, where xt+1 is the state 
vector that results from the transformation given by the monthly transition matrix 
A. A is a piecewise block-diagonal matrix that includes a block-diagonal matrix (i.e. 
A1, A2, A3) in each segment. Results: We applied our method to model relative sur-
vival for stage 3 colorectal cancer patients 75 years old and younger. The estimated 
change points were at months 9 and 37. We compared our piecewise calibration 
method to a single-segment Markov model. While the single-segment converged 
faster, the piecewise method improved the goodness of fit by 50%. ConClusions: 
By estimating the change points in the relative survival we were able to find the 
optimal transition probabilities for a piecewise Markov model. This model allowed 
us to impose a particular structure defined by the progression of the disease. We 
propose a piecewise calibration method that produces more accurate solutions 
compared to a single-segment approach.
ReseaRCh on Methods – statistical Methods
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aPPlied CoMPaRison of Meta-analysis teChniqUes
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objeCtives: Meta-analysis is an approach that combines findings from similar 
studies. The aggregation of study level data can provide precise estimates for out-
comes of interest, allow for unique treatment comparisons, and explain the differ-
ences arising from conflicting study results. Proper meta-analysis includes five basic 
steps: identify relevant studies; extract summary data from each paper; compute 
study effect sizes, perform statistical analysis; and interpret and report the results. 
This study aimed to review meta-analysis methods and their assumptions, apply 
various meta-techniques to empirical data, and compare the results from each 
method. Methods: Three different meta-analysis techniques were applied to a 
dataset looking at the effects of the bacille Calmette-Guerin (BCG) vaccine on tuber-
culosis (TB). First, a fixed-effects model was applied; then a random-effects model; 
and third meta-regression with study-level covariates were added to the model. 
Overall and stratified results, by geographic latitude were reported. Results: All 
three techniques showed statistically significant effects from the vaccination. 
However, once covariates were added, efficacy diminished. Independent variables, 
such as the latitude of the location in which the study was performed, appeared to 
be partially driving the results. ConClusions: Meta-analysis is useful for drawing 
general conclusions from a variety of studies. However, proper study and model 
selection are important to ensure the correct interpretation of results. Basic meta-
analysis models are fixed-effects, random-effects and meta-regression.
ReseaRCh on Methods – study design
PRM16
CholiC aCid deCReases the distRibUtion CoeffiCient of siMvastastin: 
a Potential foR inCReasing siMvastatin bioavailability
Djanic M, Pavlovic N, Stanimirov B, Vukmirovic S, Mikov M
Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia and Montenegro
objeCtives: Distribution coefficient is used as a quantitative measure for assessing 
a drug molecule affinity for the biological membranes. Since bile acids are known 
for their function as modifiers of drug penetration across biological membranes, 
the aim of this study was to estimate the influence of cholic acid (CA) on the distri-
bution coefficient of simvastatin (SV) which is a highly lipophilic compound with 
extremely low water-solubility and bioavailability. Methods: Distribution coeffi-
cients and logD of SV with or without CA were measured by shake-flask method in 
n-octanol/buffer systems at pH 5 and pH 7.4. SV concentrations in aqueous phase 
were determined by HPLC-DAD. In order to analyse theoretically complexation 
of SV with CA, semi-empirical PM3 method implemented in MOPAC software 
package in the Chem3D Ultra program has been applied. Results: Upon addition 
of CA, statistically significant decrease of SV logD was observed at both selected pH 
values (from 4.70±0.01 to 4.41±0.13 at pH 5, and from 4.59±0.06 to 4.40±0.04 at pH 
7.4). Analysing the molecular aggregates of SV with CA, it was observed that CA is 
PRM11
tRends of ReseaRCh Related bRazil PUblished in isPoR Meetings: a 
biblioMetRiC analysis fRoM 1998 to 2014
Nishikawa AM1, Minowa E1, Piedade AD1, Julian G2
1Evidências - Kantar Health, Campinas, Brazil, 2Evidências - Kantar Health, São Paulo, Brazil
objeCtives: Health economics and outcomes evaluations has become an indispen-
sable tool to guide decision-making processes regarding incorporation of new tech-
nologies. Since 2009, with the publication of methodological guidelines by REBRATS, 
followed by creation of the National Committee for Health Technology Incorporation 
(CONITEC), in 2011, health economics research are emerging in Brazil. Therefore, the 
aim of this study is to evaluate temporal trends and main areas of interest in scientific 
production in these fields by a bibliometric analysis. Methods: A search in the ISPOR 
Scientific Presentations Database was performed, using the term “Brazil” as keyword 
search in “Abstract” field, evaluating all results between 1998 and 2014. Abstracts were 
classified according to study characteristics (topic and subtopic), sponsorship and 
disease area. Results: Among the total of 29,759 abstracts available in ISPOR presen-
tation database, only 716 (2.4%) mentioned the term “Brazil” in the abstract, of which 
169 (23.6%) the first author was not from Brazil and 325 studies (45%) were sponsored 
by pharmaceutical companies. Up to 2006, scarce publications were found. The major-
ity of the studies (62.6%) was published from 2012 to 2014. The most studied diseases 
were cancer (16.9%), infection (5.9%), GI disorders (3.9%) and diabetes (3.1%) and 14.5% 
classified as “no specific disease”. In addition, 57.3% of the analyses were classified 
as “cost studies” and 24.1% as “Health care use & policy studies”. According to the 
subtopic, 140 (19.6%) were cost-effectiveness analysis and 73 (10.2%) budget impact 
analysis. ConClusions: This analysis showed a low rate of publication related to 
Brazil. On the other hand, the increasing number of published studies from 2012 may 
be related to CONITEC foundation. Thus, the rising number of studies observed over 
this period indicates an increase in importance of health economics as a support for 
health polices development and decision making process
PRM12
tabagisMo eM UniveRsitáRios: UMa Revisão sisteMátiCa da 
liteRatURa
Costa CK, Guerra FM, Bertolini SM
Centro Universitário de Maringá, Maringá, Brazil
objetivos: caracterizar a prevalência e o consumo de tabaco em universitários a 
partir de uma revisão sistemática da literatura, no período de 2003 a 2013. Métodos: 
A busca de artigos publicados foi feita nas bases de dados eletrônicas LILACS; 
MEDLINE e SCIELO com os descritores tabagismo e universitários. A metodologia 
PRISMA -Preferred Reporting Items for Systematic Reviews and Meta-Analyses- para 
trabalhos de revisão sistemática foi usada na pesquisa. Na análise quantitativa dos 
dados coletados aplicou-se a distribuição de frequência simples, relativa e cálculo 
de média e na qualitativa, o critério de categorização. ResultAdos: De 316 artigos 
encontrados, 62 foram incluídos por preencherem os critérios de inclusão. Deste 
total, a maioria foi publicada em espanhol (46,77%) e português (41,94%). Houve 
forte concentração de publicações nos anos de 2009 (19,35%), 2011 (22,58%) e 2012 
(17,74%). A distribuição das publicações quanto áreas das revistas, em termos nacio-
nais, mostrou que a saúde geral e a medicina tiveram maior número de publicações 
(19,35% para cada uma), seguida da enfermagem (14,51%). Para as revistas internac-
ionais, a área de medicina se destacou em 19,35%, ficando a saúde geral com 12,90%. 
Sete eixos temáticos principais foram identificados, os quais foram distintos em 
termos de metodologia, mas estavam inter-relacionados sobre os aspectos: tabag-
ismo e universitários da área da saúde (9); tabagismo e universitários de diversos 
cursos superiores (7); universitários, tabaco e outras drogas ilícitas (10); fatores que 
influenciavam o consumo tabágico em universitários (20); tabagismo e atividade 
física em universitários (6); universitários e medidas educativas sobre tabagismo (6) 
e malefícios do tabagismo em universitários (4). ConClusões: o tabagismo é um 
tema atual e relevante, pois apresentou um alto número de artigos publicados nos 
últimos anos; entretanto, estas publicações relatam divergências entre a prevalência 
e o consumo de produtos derivados do tabaco por universitários.
ReseaRCh on Methods – Modeling Methods
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PeRfil del gasto de bolsillo en MediCaMentos esenCiales en PanaMá, 
2014
Herrera Ballesteros VH
Gorgas Memorial Institute of Health Studies, Panama, Panama
objeCtivos: Obtener los perfiles socioeconómicos que caracterizan el acceso 
a los medicamentos, con base en el poder adquisitivo, disponibilidad y uso 
racional. MetodologíAs: Diseño muestral estratificado, con selección aleatoria 
en 6 dominios en el ámbito nacional, cubriendo zonas urbanas, rurales e indíge-
nas. Encuesta multipropósito de línea de base. La muestra fue de 2,696 individuos 
de 15 años y más. El instrumento recogió información sobre las características 
socioeconómicas, condiciones de salud, gasto, financiación, acceso, disponibilidad 
y uso racional de los medicamentos. El análisis estadístico, se realizó con el soft-
ware SPSS 20.0. ResultAdos: Las comarcas indígenas son las más pobres según 
la distribución del ingreso en el primer quintil, 41.9% en la Ngäbe Buglé y 62.7% en 
Madugandí. Las enfermedades crónicas (circulatorias y diabetes) y las infecciosas 
(diarrea, infecciones generales y malestar estomacal), son las principales morbili-
dades. El gasto promedio general fue USD 83.25, siendo en diabetes USD 96.81 en 
las diarreas, infecciones y malestar estomacal con USD 96.80. El 43.3% financia 
parcialmente la compra con sus ingresos y 13.0% no cuenta con los mismos, 50% 
de los medicamentos estuvieron disponibles y 61% declaró que el precio es inac-
cesible. Mientras tanto, 29% consume medicamentos sin receta, siendo mayor en 
las comarcas Ngäbe Buglé con 59% y Madugandí con 35%. La elasticidad ingreso 
resultó de 0.20 (t= 2.577, p= 0.01) indicando que los medicamentos son productos 
necesarios, con relación a la edad, por cada año adicional, el gasto en medicamentos 
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às tomadas de decisão em saúde. desenvolviMento: A Lógica Paraconsistente é 
uma opção metodológica que permite manipular dados imprecisos, inconsitentes 
e paracompletos. A aplicação do método consiste basicamente de oito etapas: 
1-fixar o nível de exigência da decisão que se pretende tomar; 2-selecionar os 
fatores mais importantes e de maior influência na decisão; 3-estabelecer as seções 
para cada um dos fatores; 4-construir a base de dados que é constituída pelos 
pesos atribuídos aos fatores e pelos valores de evidência favorável e de evidência 
contrária atribuídos a cada um dos fatores em cada uma das seções (os pesos e 
os valores das evidências são atribuídos por especialistas selecionados para o 
estudo); 5-fazer a pesquisa de campo para verificar, no caso em análise, em que 
seção (condição) cada um dos fatores se encontra; 6-obter o valor da evidência 
favorável e o valor da evidência contrária resultantes para cada um dos fatores 
escolhidos, por meio da aplicação das técnicas de maximização e minimização 
da LPAE; 7- obter o grau de evidência favorável e o grau de evidência contrária 
do baricentro dos pontos que representam os fatores escolhidos no reticulado 
paraconsistente; 8-tomar a decisão, aplicando-se a regra de decisão ou algoritmo 
para-analisador. ConClusão: Em situações em que a tomada de decisão precisa 
ser realizada em curto período de tempo, transferir e adaptar avaliações econômi-
cas realizadas em outros contextos pode ser uma necessidade considerável. O 
método paraconsistente pode contribuir nesse processo, apoiando o trabalho das 
comissões hospitalares de avaliação e incorporação de tecnologias em saúde.
disease – sPeCifiC stUdies
CanCeR – Clinical outcomes studies
PCn1
PhaRMaCovigilanCe in onCology: knowledge and PeRCePtion on 
adveRse events RePoRting in bRazil
Holtz L1, Cecilio L1, Minowa E2, Julian G3
1Oncoguia, São Paulo, Brazil, 2Evidências - Kantar Health, Campinas, Brazil, 3Evidências - Kantar 
Health, São Paulo, Brazil
objeCtives: Pharmacovigilance represents an important tool to support the 
maintenance of drug safety through evaluation of spontaneous adverse events (AE) 
reporting. AEs represent one important cause of morbidity and mortality world-
wide when not managed correctly, being very frequent, especially during oncology 
treatments. However, underreported phenomenon occurs often due inefficient 
spontaneous reporting by patients, physicians and caregivers. Therefore, the aim 
of this survey was to evaluate the knowledge and perception related to pharma-
covigilance in Brazil. Methods: From February to March 2015, 260 respondents 
answered an internet-based survey related to knowledge on pharmacovigilance 
from Oncoguia Institute, an independent nonprofit cancer advocacy institution. 
Descriptive analyses were performed according to answers frequency. Results: 
Among the respondents, 70.8% were diagnosed with cancer, of which breast cancer 
was the most frequent (58%) followed by colorectal cancer (4%). Reported treat-
ment included chemotherapy (96%), surgery (84%), 48% radiotherapy (48%). Of all, 
46% and 44% were treated by public and private health insurance, respectively. 
Most of the respondents were not aware of the importance of a pharmacovigi-
lance AE report (52%). In fact, 21% of the respondents were not aware of what AEs 
are. In 66% of the cases, physicians have described the main AE expected to the 
prescribed treatment. Respondents reported nausea (80%), hair loss (77%), weight 
gain (49%) and vomiting (45%) as the most common AEs. Only 7% and 4% of the 
respondents were aware that AEs could be reported to pharmaceutical industry 
and ANVISA, respectively. ConClusions: This survey demonstrates that knowl-
edge and perception regarding AEs, such as definition, importance and how to 
proceed in case of having one, including the importance of pharmacovigilance 
system, are very reduced among common public, including cancer patients. 
Therefore, there is an enormous need for educational intervention regarding AEs 
reporting importance in general public, patients and physicians, especially in 
oncology.
PCn2
efiCaCia y segURidad del Uso del CetUxiMab en PaCientes Con CanCeR 
ColoRReCtal MetastásiCo
Croci A1, Aleman A2, Perez Galan A2
1Ministry of Public Health, montevideo, Uruguay, 2Ministry of Public Health, Montevideo, Uruguay
objeCtivos: Determinar la eficacia y seguridad de Cetuximab solo o asociado a 
otros fármacos en el tratamiento del cáncer colo-rectal metastásico comparado a los 
tratamientos actualmente disponibles MetodologíAs: Se realizó una búsqueda 
bibliográfica de revisiones sistemáticas y Ensayos Clínicos Aleatorizados (ECAS) en 
bases electrónicas Cochrane, Pubmed y Lilacs, que compararan ramas de tratami-
ento con y sin Cetuximab ResultAdos: Se seleccionaron 2 revisiones sistemáti-
cas y 8 ECAS. Los resultados para los puntos finales de eficacia y seguridad en la 
población general fueron: Sobrevida Global (SG) HR 0,97 [0,89-1,05], Sobrevida Libre 
de Progresión (SLP) HR 0,84 [0,70-0,98], eventos adversos (EA) grado 3-4 HR 2,15 [1,88-
2,45] y reacciones de piel 44,5 [22,1-89,5]. En la población KRAS wild la SG fue HR 
0,796 IC95% [0,670-0,946] en el estudio de Van Cutsem, HR, 0,855 IC95% [0,599-1,219] 
en el estudio de Bokemeyer, 1,04 IC95% [0,87-1,23] en el estudio de Maughan y HR 
0,55 IC95% [0,41-0,74] en el estudio de Jonker. Para la SLP en población KRAS wild 
los resultados fueron HR 0,57 IC95% [0,38-0,86] en el estudio de Bokemeyer, HR 0,40 
IC95% [0,30-0,53] en el estudio de Jonker, HR 0,96 IC96% [0,82-1,12] en el estudio de 
Maughan y HR 0,70 IC95% [0,56-0,87] en el estudio de Van Cutsem ConClusiones: 
Los resultados analizados muestran un incremento en la SG en pacientes con KRAS 
wild y de la SLP. También se constata un incremento en la ocurrencia de EA graves. 
Considerando los resultados de eficacia y seguridad para Cetuximab, se recomienda 
realizar un estudio de costo-efectividad para decidir su posible inclusión en el FTM. 
En este sentido, no debe darse por concluida la evaluación hasta contar con dicha 
información.
bonded to SV by hydrophobic interactions, while OH groups are oriented towards 
the outer side of the aggregate. Hence, the formed aggregate is more hydrophilic 
than SV molecule alone. ConClusions: Our data indicate that CA decreases the 
values of SV distribution coefficient. This may be the result of the formation of 
hydrophilic complexes increasing the solubility of SV that could consequently lead 
to the increase of SV bioavailability. In order to confirm these results, further in 
vivo investigations of their interactions at molecular level need to be undertaken. 
Acknowledgement: This work is supported by Ministry of Education, Science and 
Technological Development of Serbia, Project III41012.
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RandoMized ContRolled tRials and Real-life stUdies - inflUenCe of 
stUdy design in the sUstained viRologiCal ResPonse: a systeMatiC 
Review of PUblished liteRatURe
Vaisberg VV, Kim V, Ono SK, Mendes LC, Carrilho FJ
University of São Paulo School of Medicine, São Paulo, Brazil
objeCtives: To assess whether hepatitis C treatment outcome was similar among 
different study designs. Methods: Two independent reviewers conducted a 
double-screened systematic review on hepatitis C treatment. Studies were cat-
egorized under study design: randomized controled trials (RCT), pragmatic trials 
(PRG) and registries; and treatment course: pegylated interferon and ribavirin (IR), 
IR and boceprevir (BCP), IR and telaprevir (TLP). 3,713 abstracts were retrieved, 
and 253 studies were included according to previously selected criteria, compris-
ing 77,042 patients. Sustained virological response (SVR) was stablished as treat-
ment end-point. Mann-Whitney-U and Kruskall-Wallis tests were used with a 95% 
CI. Results: In the IR group, registries had a lower SVR than PRG (P= 0.039) and than 
RCT (P= 0,3368). RCT had a worse outcome than PRG (P= 0.283). Statistical difference 
was seen among the three BCP groups (P= 0.040), and RCT had a higher SVR than 
registries (P= 0.028). BCP PRG group couldn’t be analysed in comparison to other 
study designs due to a very small group. PRG (SVR= 80.13%) had a better outcome 
than RCT (SVR= 75.00%) and than registries (SVR= 62.00%), but tests have shown 
no statistical significance among study designs (P> 0.05). ConClusions: It’s pos-
sible to design close to the real-life settings RCT. Though it’s not a rule, each drug 
should be studied separately and its clinical scenario considered. PRG might be not 
as pragmatic as they claim to be, as their results were more similar to RCT than to 
registries. Further analysis should assess whether PRG are fully bridging RCT’s gap to 
the real-life settings, as they are intent to be the main guide to drug’s embodiment to 
the clinical practice. Also, boceprevir was less studied than telaprevir, and whether 
remains unclear which drug is more effective, new data could answer that, specially 
a large proportions head-to-head RCT comparing both drugs. Although, as of new 
and better treatment courses are approved, this RCT most probably will not be done.
ReseaRCh on Methods – Conceptual Papers
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engaging hisPaniC CaRegiveRs in ReseaRCh: a fRaMewoRk to design 
CUltURally sensitive aPPRoaChes foR engageMent in  
Patient-CenteRed oUtCoMes ReseaRCh
Camelo Castillo W1, Hendricks J2, dosReis S3
1University of Maryland School of Pharmacy School of Pharmacy, Baltimore, MD, USA, 2Maryland 
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The Latin American perspective on caregivers’ preferences is underrepresented in 
research largely due to lack of culturally sensitive approaches to enhance research 
literacy. Identification of the most effective engagement strategies is needed so 
that patient centered outcomes research (PCOR) can address the needs and pri-
orities of caregivers of Latin American origin. Our objectives were to develop a 
methodological framework for engaging caregivers of Latin American origin in 
research and to improve PCOR literacy in this population. The ‘pre-engagement’ 
framework with hard-to-reach patients was used in a study designed to identify 
caregivers’ priorities for treatment and outcomes in children of Hispanic origin 
living in the U.S. with complex mental health conditions. Based on the principles 
of community based participatory research, the pre-engagement implementa-
tion phases were: 1. Identify Hispanic community leaders with common goals; 2. 
Partner with leaders to select key topics of interest; 3. Design culturally appropriate 
strategies; 4. Implement pre-engagement strategies. During phase 1, academic 
partnerships were developed with community leaders to allow integration into the 
research process. Community needs and practical challenges to engage caregivers 
and the strategies to overcome barriers were identified during phase 2. In phase 
3, a series of four workshops, delivered in Spanish, were designed as interac-
tive activities each addressing a unique challenge: understanding the caregiver’s 
perspective, understanding the child’s perspective, providing behavior manage-
ment strategies, and discussing community resources for families. Each workshop 
emphasized research literacy by linking the benefit of research in advancing the 
challenge being discussed. An outcome of this work will be a caregiver resource 
guide in Spanish, developed by Hispanic community leaders, for distribution in 
their communities. In the absence of culturally appropriate tools to address health 
and medical preferences of non-English speaking communities, this framework 
can be used to engage caregivers and communities in patient-centered research.
PRM19
o Método PaRaConsistente CoMo sUPoRte Às toMadas de deCisão eM 
saúde
Campolina AG, Costa A, López RV
Cancer Institute of the State of São Paulo, Sao Paulo, Brazil
intRodução: O presente estudo objetiva apresentar a Lógica Paraconsistente 
Anotada Evidencial (LPAE), que é a base teórica para o modelo proposto de suporte 
